|
1.
|
Guarneri V and Conte P: Metastatic breast
cancer: therapeutic options according to molecular subtypes and
prior adjuvant therapy. Oncologist. 14:645–656. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Decensi A, Dunn BK, Puntoni M, Gennari A
and Ford LG: Exemestane for breast cancer prevention: a critical
shift? Cancer Discov. 2:25–40. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Pillé JY, Denoyelle C, Varet J, Bertrand
JR, Soria J, Opolon P, Lu H, Pritchard LL, Vannier JP, Malvy C,
Soria C and Li H: Anti-RhoA and anti-RhoC siRNAs inhibit the
proliferation and invasiveness of MDA-MB-231 breast cancer cells in
vitro and in vivo. Mol Ther. 11:267–274. 2005.PubMed/NCBI
|
|
4.
|
Pillé JY, Li H, Blot E, Bertrand JR,
Pritchard LL, Opolon P, Maksimenko A, Lu H, Vannier JP, Soria J,
Malvy C and Soria C: Intravenous delivery of anti-RhoA small
interfering RNA loaded in nanoparticles of chitosan in mice: safety
and efficacy in xenografted aggressive breast cancer. Hum Gene
Ther. 17:1019–1026. 2006.PubMed/NCBI
|
|
5.
|
Nobes CD and Hall A: Rho, rac, and cdc42
GTPases regulate the assembly of multimolecular focal complexes
associated with actin stress fibers, lamellipodia, and filopodia.
Cell. 81:53–62. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Schmitz AA, Govek EE, Böttner B and Van
Aelst L: Rho GTPases: signaling, migration, and invasion. Exp Cell
Res. 261:1–12. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Del Re DP, Miyamoto S and Brown JH: Focal
adhesion kinase as a RhoA-activable signaling scaffold mediating
Akt activation and cardiomyocyte protection. J Biol Chem.
283:35622–35629. 2008.PubMed/NCBI
|
|
8.
|
Cardone RA, Bagorda A, Bellizzi A, Busco
G, Guerra L, Paradiso A, Casavola V, Zaccolo M and Reshkin SJ:
Protein kinase A gating of a pseudopodial-located
RhoA/ROCK/p38/NHE1 signal module regulates invasion in breast
cancer cell lines. Mol Biol Cell. 16:3117–3127. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Gutjahr MC, Rossy J and Niggli V: Role of
Rho, Rac, and Rho-kinase in phosphorylation of myosin light chain,
development of polarity, and spontaneous migration of Walker 256
carcinosarcoma cells. Exp Cell Res. 308:422–438. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Gou L, Wang W, Tong A, Yao Y, Zhou Y, Yi C
and Yang J: Proteomic identification of RhoA as a potential
biomarker for proliferation and metastasis in hepatocellular
carcinoma. J Mol Med. 89:817–827. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Leve F and Morgado-Díaz JA: Rho GTPase
signaling in the development of colorectal cancer. J Cell Biochem.
113:2549–2559. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Horiuchi A, Kikuchi N, Osada R, Wang C,
Hayashi A, Nikaido T and Konishi I: Overexpression of RhoA enhances
peritoneal dissemination: RhoA suppression with Lovastatin may be
useful for ovarian cancer. Cancer Sci. 99:2532–2539. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Liu Y, Wang Y, Zhang Y, Miao Y, Zhao Y,
Zhang PX, Jiang GY, Zhang JY, Han Y, Lin XY, Yang LH, Li QC, Zhao C
and Wang EH: Abnormal expression of p120-catenin, E-cadherin, and
small GTPases is significantly associated with malignant phenotype
of human lung cancer. Lung Cancer. 63:375–382. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Balasuriya D, Stewart AP, Crottès D,
Borgese F, Soriani O and Edwardson JM: The sigma-1 receptor binds
to the Nav1.5 voltage-gated Na+ channel with 4-fold
symmetry. J Biol Chem. 287:37021–37029. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Gillet L, Roger S, Besson P, Lecaille F,
Gore J, Bougnoux P, Lalmanach G and Le Guennec JY: Voltage-gated
sodium channel activity promotes cysteine cathepsin-dependent
invasiveness and colony growth of human cancer cells. J Biol Chem.
284:8680–8691. 2009. View Article : Google Scholar
|
|
16.
|
House CD, Vaske CJ, Schwartz AM, Obias V,
Frank B, Luu T, Sarvazyan N, Irby R, Strausberg RL, Hales TG,
Stuart JM and Lee NH: Voltage-gated Na+ channel SCN5A is
a key regulator of a gene transcriptional network that controls
colon cancer invasion. Cancer Res. 70:6957–6967. 2010.PubMed/NCBI
|
|
17.
|
Hernandez-Plata E, Ortiz CS,
Marquina-Castillo B, Medina-Martinez I, Alfaro A, Berumen J, Rivera
M and Gomora JC: Overexpression of NaV 1.6 channels is associated
with the invasion capacity of human cervical cancer. Int J Cancer.
130:2013–2023. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Diss JK, Fraser SP and Djamgoz MB:
Voltage-gated Na+ channels: multiplicity of expression,
plasticity, functional implications and pathophysiological aspects.
Eur Biophys J. 33:180–193. 2004.
|
|
19.
|
Fraser SP, Diss JK, Chioni AM, Mycielska
ME, Pan H, Yamaci RF, Pani F, Siwy Z, Krasowska M, Grzywna Z,
Brackenbury WJ, Theodorou D, Koyutürk M, Kaya H, Battaloglu E, De
Bella MT, Slade MJ, Tolhurst R, Palmieri C, Jiang J, Latchman DS,
Coombes RC and Djamgoz MB: Voltage-gated sodium channel expression
and potentiation of human breast cancer metastasis. Clin Cancer
Res. 11:5381–5389. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Brackenbury WJ, Chioni AM, Diss JK and
Djamgoz MB: The neonatal splice variant of Nav1.5 potentiates in
vitro invasive behaviour of MDA-MB-231 human breast cancer cells.
Breast Cancer Res Treat. 101:149–160. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Brisson L, Gillet L, Calaghan S, Besson P,
Le Guennec JY, Roger S and Gore J: Na(V)1.5 enhances breast cancer
cell invasiveness by increasing NHE1-dependent H(+) efflux in
caveolae. Oncogene. 30:2070–2076. 2011.PubMed/NCBI
|
|
22.
|
Yang M, Kozminski DJ, Wold LA, Modak R,
Calhoun JD, Isom LL and Brackenbury WJ: Therapeutic potential for
phenytoin: targeting Na(v)1.5 sodium channels to reduce migration
and invasion in metastatic breast cancer. Breast Cancer Res Treat.
134:603–615. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Chioni AM, Shao D, Grose R and Djamgoz MB:
Protein kinase A and regulation of neonatal Nav1.5 expression in
human breast cancer cells: activity-dependent positive feedback and
cellular migration. Int J Biochem Cell Biol. 42:346–358. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Denoyelle C, Vasse M, Körner M, Mishal Z,
Ganné F, Vannier JP, Soria J and Soria C: Cerivastatin, an
inhibitor of HMG-CoA reductase, inhibits the signaling pathways
involved in the invasiveness and metastatic properties of highly
invasive breast cancer cell lines: an in vitro study.
Carcinogenesis. 22:1139–1148. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Vincent L, Chen W, Hong L, Mirshahi F,
Mishal Z, Mirshahi-Khorassani T, Vannier JP, Soria J and Soria C:
Inhibition of endothelial cell migration by cerivastatin, an
HMG-CoA reductase inhibitor: contribution to its anti-angiogenic
effect. FEBS Lett. 495:159–166. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Onkal R and Djamgoz MB: Molecular
pharmacology of voltage-gated sodium channel expression in
metastatic disease: clinical potential of neonatal Nav1.5 in breast
cancer. Eur J Pharmacol. 625:206–219. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Gao R, Wang J, Shen Y, Lei M and Wang Z:
Functional expression of voltage-gated sodium channels Nav1.5 in
human breast cancer cell line MDA-MB-231. J Huazhong Univ Sci
Technolog Med Sci. 29:64–67. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Liu M, Bi F, Zhou X and Zheng Y: Rho
GTPase regulation by miRNAs and covalent modifications. Trends Cell
Biol. 22:365–373. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
David M, Petit D and Bertoglio J: Cell
cycle regulation of Rho signaling pathways. Cell Cycle.
11:3003–3010. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Rolli-Derkinderen M, Sauzeau V, Boyer L,
Lemichez E, Baron C, Henrion D, Loirand G and Pacaud P:
Phosphorylation of serine 188 protects RhoA from
ubiquitin/proteasome-mediated degradation in vascular smooth muscle
cells. Circ Res. 96:1152–1160. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Von Zee CL and Stubbs EB Jr:
Geranylgeranylation facilitates proteasomal degradation of rho
G-proteins in human trabecular meshwork cells. Invest Ophthalmol
Vis Sci. 52:1676–1683. 2011.PubMed/NCBI
|
|
32.
|
Rao JN, Li L, Golovina VA, Platoshyn O,
Strauch ED, Yuan JX and Wang JY: Ca2+-RhoA signaling
pathway required for polyamine-dependent intestinal epithelial cell
migration. Am J Physiol Cell Physiol. 280:993–1007. 2001.
|
|
33.
|
Uysal-Onganer P and Djamgoz MB: Epidermal
growth factor potentiates in vitro metastatic behaviour of human
prostate cancer PC-3M cells: involvement of voltage-gated sodium
channel. Mol Cancer. 6:762007. View Article : Google Scholar
|
